Trial Profile
FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2012
Price :
$35
*
At a glance
- Drugs Tetomilast (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Acronyms FACTS-I
- 15 May 2012 New trial record